AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Investors seeking reliable dividends and healthcare exposure often find themselves choosing between AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE). Both…
2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts
It’s safe to say the healthcare sector isn’t renowned as a repository of dividend-paying companies. Yet some not…
If You Have $500,000 Saved at 60, Here’s The Sort of Monthly Income You Can Count On
Verizon (VZ) yields 5.4% at its current price, paying $0.69 per quarter and offering higher current income for…
ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression
AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…